NEXMAB

Pharmaceuticals, namely, monoclonal antibodies and fragments therefor for therapeutic purposes, namely the treatment and diagnosis of cancer, proliferative cell diseases, autoimmune diseases, infectious diseases, inflammatory diseases and genetic diseases

Pharmaceutical and biological product development for others relating to monoclonal antibodies; consultation in the field of pharmaceutical and biological product development relating to monoclonal antibodies